Adult-onset Generalized Morphea

University Hospital, Strasbourg, France100 enrolled

Overview

This study aimed to describe the demographical and clinical characteristics of a retrospective cohort of adult-onset GM and to investigate whether these findings differ between patients with an isomorphic and a symmetric pattern of lesion distribution.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Generalized Morphea

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age of onset ≥ 18 years * Patients with generalized morphea as defined by criteria established by Laxer and Zulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency to confluence and involve at least 2 different anatomic sites) * Availability of good-quality clinical photographs * Patient who, after being informed, has not expressed his or her opposition to the re-use of his or her data for the purposes of this research Exclusion Criteria: * Patients with linear morphea who met criteria for generalized morphea * Patient's opposition to participate

Locations (1)

Service de dermatologie - Hôpital Civil de Strasbourg

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Retrospective study of generalized morphea in adult patients consulted in dermatology departments

Time frame: Files analyzed retrospectily from January 1st, 2019 to September 30, 2019 will be examined

Central Contacts

Cédric LENORMAND, MD

CONTACT

33 3 88 11 66 27 cedric.lenormand@chru-strasbourg.fr

Antoine BRAUD, MD

CONTACT

33 3 88 11 66 27 antoine.braud@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.